**Question:** If given in 1st trimester of pregnancy, Warfarin therapy leads to which problem?

**Core Concept:** Warfarin is an anticoagulant drug primarily used to prevent blood clots, stroke, and pulmonary embolism. In pregnancy, there is a unique risk associated with its use in the first trimester.

**Why the Correct Answer is Right:** Warfarin's use during pregnancy, especially in the first trimester, poses risks to the developing foetus. The drug crosses the placenta and can cause severe malformations, particularly in the cardiovascular system. This is due to the interference with the synthesis of vitamin K-dependent proteins, which are essential for blood clotting and vessel development in the foetus.

**Why Each Wrong Option is Incorrect:**

A. Option A (Anencephaly) is a type of neural tube defect where the brain and skull are underdeveloped, but it is not directly associated with Warfarin use in pregnancy.

B. Option B (Hydrops fetalis) is a severe and potentially life-threatening condition in the foetus characterized by fluid accumulation, but it is not directly linked to Warfarin use in the first trimester.

C. Option C (Edwards syndrome) is a chromosomal disorder caused by the presence of an extra chromosome 18, not a direct consequence of Warfarin exposure during pregnancy.

D. Option D (Fetal growth retardation) is a potential consequence of any medication exposure during pregnancy, including Warfarin. However, it is not unique to Warfarin use in the first trimester.

**Core Concept:** Warfarin is an anticoagulant drug that interferes with blood clotting and vascular development in the foetus due to its effect on vitamin K-dependent protein synthesis.

**Why the Correct Answer is Right:**

Warfarin therapy in the first trimester of pregnancy can lead to severe cardiovascular malformations in the foetus due to its interference with the synthesis of vitamin K-dependent proteins, which are crucial for blood clotting and vascular development.

**Why Each Wrong Option is Incorrect:**

A. Option A (Anencephaly) is a type of neural tube defect involving incomplete brain and skull development, which is unrelated to Warfarin use in pregnancy.

B. Option B (Hydrops fetalis) is a severe condition characterized by excessive fluid accumulation in the foetus, but it is not directly linked to Warfarin exposure during pregnancy.

C. Option C (Edwards syndrome) is a chromosomal disorder caused by an extra chromosome 18, unrelated to Warfarin exposure during pregnancy.

D. Option D (Foetal growth retardation) is a potential consequence of any medication exposure during pregnancy, including Warfarin. However, it is not unique to Warfarin use in the first trimester.

**Clinical Pearl:** Given the potential risks associated with Warfarin use in the first trimester, healthcare professionals should consider alternative anticoagulant therapies or defer treatment if possible to minimize the